Citigroup Inc Alx Oncology Holdings Inc Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Citigroup Inc holds 25,552 shares of ALXO stock, worth $46,760. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,552

Previous 8,292 208.15%

Holding current value

$46,760

Previous $50,000 8.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1.81 - $8.13 $31,240 - $140,323	17,260 Added 208.15%	25,552 $46,000
Q2 2024 Aug 12, 2024	SELL	$5.84 - $17.56 $205,655 - $618,375	-35,215 Reduced 80.94%	8,292 $50,000
Q1 2024 May 10, 2024	BUY	$10.95 - $16.79 $424,465 - $650,847	38,764 Added 817.29%	43,507 $485,000
Q4 2023 Feb 09, 2024	BUY	$4.81 - $15.38 $20,298 - $64,903	4,220 Added 806.88%	4,743 $70,000
Q3 2023 Nov 09, 2023	SELL	$4.19 - $7.35 $27,721 - $48,627	-6,616 Reduced 92.67%	523 $2,000
Q2 2023 Aug 10, 2023	BUY	$4.37 - $9.56 $27,155 - $59,405	6,214 Added 671.78%	7,139 $53,000
Q1 2023 May 11, 2023	SELL	$4.52 - $11.71 $854 - $2,213	-189 Reduced 16.97%	925 $4,000
Q4 2022 Feb 09, 2023	SELL	$9.51 - $12.95 $1,350 - $1,838	-142 Reduced 11.31%	1,114 $12,000
Q3 2022 Nov 10, 2022	SELL	$8.23 - $15.14 $10,995 - $20,227	-1,336 Reduced 51.54%	1,256 $12,000
Q2 2022 Aug 10, 2022	SELL	$5.89 - $19.46 $133,060 - $439,620	-22,591 Reduced 89.71%	2,592 $21,000
Q1 2022 May 12, 2022	SELL	$13.65 - $22.06 $839,393 - $1.36 Million	-61,494 Reduced 70.95%	25,183 $426,000
Q4 2021 Feb 10, 2022	BUY	$21.49 - $74.4 $1.36 Million - $4.71 Million	63,311 Added 270.95%	86,677 $1.86 Million
Q3 2021 Nov 10, 2021	BUY	$52.51 - $80.91 $1.23 Million - $1.89 Million	23,366 New	23,366 $1.73 Million

Others Institutions Holding ALXO

# of Institutions

101

Shares Held

39.7M

Call Options Held

134K

Put Options Held

17.4K

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $74.6M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account